X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2867231/0/en/Cellectis-Presents-Novel-TALEN-Editing-Processes-Enabling-Highly-Efficient-Gene-Correction-and-Gene-Insertion-in-HSPCs.html
https://www.globenewswire.com/news-release/2024/04/10/2861129/0/en/Cellectis-Publishes-a-Novel-Intronic-Gene-Editing-Approach-For-the-Treatment-of-Inborn-Metabolic-Diseases-by-Edited-HSPCs.html
https://www.globenewswire.com/news-release/2024/04/08/2859598/0/en/Cellectis-Announces-Two-Poster-Presentations-on-Novel-TALEN-Editing-Process-for-Gene-Correction-and-Gene-Insertion-in-HSPCs-at-the-ASGCT-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/04/2858222/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html
https://www.globenewswire.com//news-release/2024/03/04/2839998/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html
https://www.globenewswire.com//news-release/2024/02/02/2823064/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html
https://www.globenewswire.com//news-release/2024/01/16/2810340/0/en/Cellectis-announces-the-drawdown-of-the-second-tranche-of-15-million-under-the-credit-facility-agreement-entered-with-the-European-Investment-Bank-EIB.html
https://www.globenewswire.com//news-release/2024/01/08/2805869/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html
https://www.globenewswire.com/news-release/2023/12/22/2800843/0/en/Cellectis-Reports-Results-from-Shareholders-Meeting-Held-on-December-22-2023.html
https://endpts.com/cellectis-shifts-car-t-manufacturing-in-house-boosts-efficacy-compared-to-third-party-cdmos-ash23/
Market Place
Share 
